Arsenal Announces Sale Of Certara, Retains Significant Minority Investment Stake
July 11, 2017
New York – Arsenal Capital Partners (“Arsenal”) today announced that it has agreed to sell its portfolio company, Certara (the “Company”), the leading provider of technology-driven decision support solutions for drug development, to EQT VII Fund for an enterprise value of $850 million. As part of the transaction, Arsenal Capital Partners will retain a minority ownership [...]
Linkage Biosciences™ is now a part of Thermo Fisher Scientific™
July 11, 2017
Linkage Biosciences joins Thermo Fisher Scientific's Transplant Diagnostics business, which now represents both the One Lambda™ and Linkage Biosciences brands. We are united in our core belief that improving the lives of transplant patients worldwide is our ultimate objective. For our HLA and Transplant customers, we remain firmly committed to bringing you quality reagents and [...]
Collaboration with Twist Bioscience
July 11, 2017
SAN FRANCISCO, Calif. – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it signed a non-exclusive agreement with Synbio Technologies. The companies will partner their respective capabilities to provide customers with access to long-length genes up to 70 kilobases. “We are thrilled to partner with Twist Bioscience [...]
EQT VII acquires health technology company Certara for USD 850 million
July 11, 2017
EQT VII acquires Certara, the global leader in model-informed (in silico) drug development and regulatory science, focused on optimizing drug development and improving health outcomes Certara’s solutions help to inform and accelerate drug development and regulatory approval processes, while addressing the key efficacy, safety, productivity and commercial challenges facing the biopharma industry EQT VII to [...]
July 11, 2017
Laughton, United Kingdom, 11th July 2017: Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, talk about how the Blackett Laboratory of the Physics Department at Imperial College chose the Q150T coater to deposit metals to make plasmonic devices in a fast prototyping and development process. Dr Avi Braun is [...]
July 11, 2017
Groundbreaking ceremony for the new production hall of Anton Paar ShapeTec BA in Bosnia. Anton Paar ShapeTec BA is moving its site from Derventa, which was a rented location, to the close area of Sijekovac. There, a 1,900 square meter building is build. It will be finished by December at the latest and opened in [...]
July 11, 2017
Thermo Scientific Sterilin containers suitable for molecular biology and genomic and forensic applications WALTHAM, Mass. -- For the rigorous requirements of molecular biology, genomic and forensic research facilities, new universal containers are specifically lot tested and certified to be free from RNase, DNase, human DNA and pyrogens. Thermo Scientific Sterilin quality-assured containers are aseptically manufactured under controlled, automated [...]
July 11, 2017
Enhanced sensitivity and selectivity for small and large molecule quantitation address complex environmental analysis and agricultural markets Framingham, MA — SCIEX, a global leader in life science analytical technologies, announced today that EPL Bio Analytical Services, (EPL BAS), an industry leading agriculture-focused analytical contract laboratory, has selected the SCIEX QTRAP® 6500+ with SelexION®+, enabling their researchers to [...]
July 11, 2017
MADISON, WI USA Promega Corporation has become the first major forensic manufacturer to achieve third-party certification of the published ISO 18385 standard to minimize the risk of human DNA contamination in products used to collect, store and analyze biological material for forensic purposes. This Forensic DNA Grade certification comes following a recent onsite audit by [...]
SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology
July 11, 2017
WOBURN, Mass.--SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single Molecule Sequencing (tSMS™) platform. The Phase I grant will allow SeqLL to improve DRS [...]
